Recent updates of centromere proteins in hepatocellular carcinoma: a review

Abstract Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related death worldwide, with approximately 800,000 deaths worldwide each year. Owing to the atypical early symptoms and characteristics of HCC, over 80% of HCC patients cannot receive curative treatment. The treatment of...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhongyuan Yang, Wenjiao Chen, Yunhui Liu, Yuxin Niu
Format: Article
Language:English
Published: BMC 2025-02-01
Series:Infectious Agents and Cancer
Subjects:
Online Access:https://doi.org/10.1186/s13027-024-00630-2
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823863289844596736
author Zhongyuan Yang
Wenjiao Chen
Yunhui Liu
Yuxin Niu
author_facet Zhongyuan Yang
Wenjiao Chen
Yunhui Liu
Yuxin Niu
author_sort Zhongyuan Yang
collection DOAJ
description Abstract Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related death worldwide, with approximately 800,000 deaths worldwide each year. Owing to the atypical early symptoms and characteristics of HCC, over 80% of HCC patients cannot receive curative treatment. The treatment of HCC is facing a bottleneck, and new treatment methods are urgently needed. Since the pathogenesis of HCC is not yet clear, identifying the molecular mechanisms and therapeutic targets related to it is crucial. Centromeres are considered special deoxyribonucleic acid (DNA) sequences with highly repetitive sequences that are physically connected to the spindle during cell division, ensuring equal division of genetic material between daughter cells. The numerous proteins that aggregate on this sequence during cell division are called centromere proteins (CENPs). Currently, numerous studies have shown that CENPs are abnormally expressed in tumor cells and are associated with patient prognosis. The abnormal expression of CENPs is a key cause of chromosomal instability. Furthermore, chromosomal instability is a common characteristic of the majority of tumors. Chromosomal instability can lead to uncontrolled and sustained division and proliferation of malignant tumors. Therapeutic plans targeting CENPs play important roles in the treatment of HCC. For example, small ribonucleic acid (RNA) can silence CENP expression and prevent the occurrence and development of liver cancer. In recent years, studies of HCC-targeting CENPs have gradually increased but are still relatively novel, requiring further systematic elaboration. In this review, we provide a detailed introduction to the characteristics of CENPs and discuss their roles in HCC. In addition, we discuss their application prospects in future clinical practice.
format Article
id doaj-art-9e2dcfeca61f4f11b9a87b054976fd62
institution Kabale University
issn 1750-9378
language English
publishDate 2025-02-01
publisher BMC
record_format Article
series Infectious Agents and Cancer
spelling doaj-art-9e2dcfeca61f4f11b9a87b054976fd622025-02-09T12:13:10ZengBMCInfectious Agents and Cancer1750-93782025-02-0120111210.1186/s13027-024-00630-2Recent updates of centromere proteins in hepatocellular carcinoma: a reviewZhongyuan Yang0Wenjiao Chen1Yunhui Liu2Yuxin Niu3Department of Infectious Diseases, Tongji Hospital, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonostic Infectious Disease, Huazhong University of Science and TechnologyDepartment of Dermatology, Wuhan Hankou HospitalDepartment of Infectious Diseases, Tongji Hospital, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonostic Infectious Disease, Huazhong University of Science and TechnologyDepartment of Infectious Diseases, Tongji Hospital, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonostic Infectious Disease, Huazhong University of Science and TechnologyAbstract Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related death worldwide, with approximately 800,000 deaths worldwide each year. Owing to the atypical early symptoms and characteristics of HCC, over 80% of HCC patients cannot receive curative treatment. The treatment of HCC is facing a bottleneck, and new treatment methods are urgently needed. Since the pathogenesis of HCC is not yet clear, identifying the molecular mechanisms and therapeutic targets related to it is crucial. Centromeres are considered special deoxyribonucleic acid (DNA) sequences with highly repetitive sequences that are physically connected to the spindle during cell division, ensuring equal division of genetic material between daughter cells. The numerous proteins that aggregate on this sequence during cell division are called centromere proteins (CENPs). Currently, numerous studies have shown that CENPs are abnormally expressed in tumor cells and are associated with patient prognosis. The abnormal expression of CENPs is a key cause of chromosomal instability. Furthermore, chromosomal instability is a common characteristic of the majority of tumors. Chromosomal instability can lead to uncontrolled and sustained division and proliferation of malignant tumors. Therapeutic plans targeting CENPs play important roles in the treatment of HCC. For example, small ribonucleic acid (RNA) can silence CENP expression and prevent the occurrence and development of liver cancer. In recent years, studies of HCC-targeting CENPs have gradually increased but are still relatively novel, requiring further systematic elaboration. In this review, we provide a detailed introduction to the characteristics of CENPs and discuss their roles in HCC. In addition, we discuss their application prospects in future clinical practice.https://doi.org/10.1186/s13027-024-00630-2Hepatocellular carcinomaCentromere proteinChromosomal instabilityTherapeutic target
spellingShingle Zhongyuan Yang
Wenjiao Chen
Yunhui Liu
Yuxin Niu
Recent updates of centromere proteins in hepatocellular carcinoma: a review
Infectious Agents and Cancer
Hepatocellular carcinoma
Centromere protein
Chromosomal instability
Therapeutic target
title Recent updates of centromere proteins in hepatocellular carcinoma: a review
title_full Recent updates of centromere proteins in hepatocellular carcinoma: a review
title_fullStr Recent updates of centromere proteins in hepatocellular carcinoma: a review
title_full_unstemmed Recent updates of centromere proteins in hepatocellular carcinoma: a review
title_short Recent updates of centromere proteins in hepatocellular carcinoma: a review
title_sort recent updates of centromere proteins in hepatocellular carcinoma a review
topic Hepatocellular carcinoma
Centromere protein
Chromosomal instability
Therapeutic target
url https://doi.org/10.1186/s13027-024-00630-2
work_keys_str_mv AT zhongyuanyang recentupdatesofcentromereproteinsinhepatocellularcarcinomaareview
AT wenjiaochen recentupdatesofcentromereproteinsinhepatocellularcarcinomaareview
AT yunhuiliu recentupdatesofcentromereproteinsinhepatocellularcarcinomaareview
AT yuxinniu recentupdatesofcentromereproteinsinhepatocellularcarcinomaareview